Evaluation of Frailty as an Unmeasured Confounder in Observational Studies of Antidiabetic Medications

摘要

BackgroundIt is unknown whether observational studies evaluating the association between antidiabetic medications and mortality adequately account for frailty. Our objectives were to evaluate if frailty was a potential confounder in the relationship between antidiabetic medication regimen and mortality and how well administrative and clinical electronic health record (EHR) data account for frailty.